Results

Total Results: 564 records

Showing results for "past months".

1. Observed Association Between Antidepressant Use and Pneumonia Risk Was Confounded by Comorbidity Measures (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-seniors-pneumonia_research.pdf
   May 01, 2008 - The incidence of pneumonia is expected to peak during the winter months and decline during the summer … , ever past benzodiazepine prescription, and ever past antipsychotic prescription) the OR (95% CI) was … , ever past benzodiazepine prescription, and ever past antipsychotic prescription) the OR (95% CI) was … ever past benzodiazepine prescription, and ever past antipsychotic prescription § Adjusted for age, … prescriptions in the prior month, ever past benzodiazepine prescription, and ever past antipsychotic

2. Rapid Evidence Product: Misuse of ADHD Prescription Stimulants in Adults (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-adhd-prescription-rapid-research.pdf
   July 01, 2025 - : 7.5% of students used ADHD stimulants in past 4 months. … : 14.5% had ever misused; of these, 56.2% had misused at least once in the past 12 months. … : In the past 12 months: 1-9 times 43%, 10-19 times 7%, 20-49 times 4%, 50 or more times 2%. … : 12.2% reported misuse at least once in past 3 months. … : 8% engaged in misuse in past 12 months.

3. Back-Pain-Imaging Clinician (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-imaging_clinician.pdf
   April 01, 2016 - Secondary patient-reported outcomes included average back pain intensity in the past week, average … leg pain intensity in the past week, pain interference with activities, depression and anxiety, health … - related quality of life, and falls in the past 3 weeks; these outcomes were assessed at 3, 6, and … 12 months. … and better health status at 12 months, but these differences were small and clinically unimportant

4. App-D-Surv-Report-1-Noninvasive-Nonpharma 0 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
   January 01, 2021 - 4.62) vs. 23.93 (4.68) Oswestry Disability Index (ODI) (range 0-100) Average pain intensity over the past … knee pain intensity over 40 mm on a visual analogue scale (VAS) that ranged from 0 to 100 mm, in the past … infection of the knee; 3) had a history of knee trauma, ligament damage, fracture, or surgery in the past … within the past 3 months; 5) had received acupuncture, electro-acupuncture, tui-an therapy, massage, … or physiotherapy within the past 8 weeks Randomized: 86 Analyzed: 83 Attrition: 10.5% (9/86) A.

5. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
   January 01, 2021 - 4.62) vs. 23.93 (4.68) Oswestry Disability Index (ODI) (range 0-100) Average pain intensity over the past … knee pain intensity over 40 mm on a visual analogue scale (VAS) that ranged from 0 to 100 mm, in the past … infection of the knee; 3) had a history of knee trauma, ligament damage, fracture, or surgery in the past … within the past 3 months; 5) had received acupuncture, electro-acupuncture, tui-an therapy, massage, … or physiotherapy within the past 8 weeks Randomized: 86 Analyzed: 83 Attrition: 10.5% (9/86) A.

6. Disclosure Policy and Form (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/epc-disclosure-policy-form.pdf
   March 01, 2023 - months or anticipated in the next 12 months). … 12 months and anticipated over the next 12 months directly to you, to your institution on your behalf … months or anticipated in the next 12 months).  … The EPC should maintain the Disclosure Forms for 6 years past delivery of the final report.   … 12 months and anticipated over the next 12 months directly to you, to your institution on your behalf

7. Cer-250-Cannabis-Table-E5-2022-Update 0 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-table-e5-2022-update_0.xlsx
   January 01, 2022 - NR + 1.75 mg/d 3 months: 3.15 mg/d vs. 2,372 mg/d vs. … NR + 2.85 mg/d 6 months: 3.05 mg/d + 2,295.5 mg/d vs. … , severity of chronic pain, pain phenotype, pain duration, mean 24-hour pain intensity, current and past … NA 84 (21 months) Long NR None NR NR NR NR NR A vs. … B VAS (0-10 [range]): 6.6 (0-10) vs. 6.1 (0-10) Past cannabis use NR NR NR NR NR NR A vs.

8. App-D-Surv-Report-3-Noninvasive-Nonpharma 0 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
   January 01, 2022 - 4.62) vs. 23.93 (4.68) Oswestry Disability Index (ODI) (range 0-100) Average pain intensity over the past … knee pain intensity over 40 mm on a visual analogue scale (VAS) that ranged from 0 to 100 mm, in the past … infection of the knee; 3) had a history of knee trauma, ligament damage, fracture, or surgery in the past … within the past 3 months; 5) had received acupuncture, electro-acupuncture, tui-an therapy, massage, … or physiotherapy within the past 8 weeks Randomized: 86 Analyzed: 83 Attrition: 10.5% (9/86) A.

9. Cannabis-2022-Surv-Rep-3-Table-F5 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
   January 01, 2022 - NR + 1.75 mg/d 3 months: 3.15 mg/d vs. 2,372 mg/d vs. … NR + 2.85 mg/d 6 months: 3.05 mg/d + 2,295.5 mg/d vs. … , severity of chronic pain, pain phenotype, pain duration, mean 24-hour pain intensity, current and past … NA 84 (21 months) Long NR None NR NR NR NR NR A vs. … B VAS (0-10 [range]): 6.6 (0-10) vs. 6.1 (0-10) Past cannabis use NR NR NR NR NR NR A vs.

10. Cannabis-2022-Update-Surv-Rep-1-App-F-5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
    January 01, 2022 - NR + 1.75 mg/d 3 months: 3.15 mg/d vs. 2,372 mg/d vs. … NR + 2.85 mg/d 6 months: 3.05 mg/d + 2,295.5 mg/d vs. … , severity of chronic pain, pain phenotype, pain duration, mean 24-hour pain intensity, current and past … NA 84 (21 months) Long NR None NR NR NR NR NR A vs. … B VAS (0-10 [range]): 6.6 (0-10) vs. 6.1 (0-10) Past cannabis use NR NR NR NR NR NR A vs.

11. Heart-Failure-Transition-Care Clinician (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-transition-care_clinician.pdf
    October 01, 2015 - all-cause readmissions (high strength of evidence [SOE]*) and mortality (moderate SOE) over 3 to 6 months … telephone support reduced HF-specific readmissions (high SOE) and mortality (moderate SOE) over 3 to 6 months … HF hospitalizations in the United States have declined by almost 30 percent during the past decade. … national data show no evidence that readmission rates for patients with HF have fallen during the past … (low SOE) but not at 6 months (low SOE). �� Emergency room (ER) visits: Evidence was insufficient

12. Appendix-E-Table-E5 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5_0.xlsx
    May 29, 2025 - NR + 1.75 mg/d 3 months: 3.15 mg/d vs. 2,372 mg/d vs. … NR + 2.85 mg/d 6 months: 3.05 mg/d + 2,295.5 mg/d vs. … NR 6 months: 38% (21/49) vs. 48% (31/52) vs. … . 23% (12/52) vs. 9% (5/55) Sedation 3 months: 31% (15/49) vs. 54% (28/52) vs. 33% (18/55) 6 months: … B VAS (0-10 [range]): 6.6 (0-10) vs. 6.1 (0-10) Past cannabis use NR NR NR NR NR NR A vs.

13. Cannabis-App-F5-Table-Surveillance-Report-2 0 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0_0.xlsx
    May 29, 2025 - NR + 1.75 mg/d 3 months: 3.15 mg/d vs. 2,372 mg/d vs. … NR + 2.85 mg/d 6 months: 3.05 mg/d + 2,295.5 mg/d vs. … NR 6 months: 38% (21/49) vs. 48% (31/52) vs. … . 23% (12/52) vs. 9% (5/55) Sedation 3 months: 31% (15/49) vs. 54% (28/52) vs. 33% (18/55) 6 months: … B VAS (0-10 [range]): 6.6 (0-10) vs. 6.1 (0-10) Past cannabis use NR NR NR NR NR NR A vs.

14. Cannabis-2023-Surv-Rep-4-Table-E-5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-table-E-5.xlsx
    January 01, 2023 - NR + 1.75 mg/d 3 months: 3.15 mg/d vs. 2,372 mg/d vs. … NR + 2.85 mg/d 6 months: 3.05 mg/d + 2,295.5 mg/d vs. … , severity of chronic pain, pain phenotype, pain duration, mean 24-hour pain intensity, current and past … NA 84 (21 months) Long NR None NR NR NR NR NR A vs. … B VAS (0-10 [range]): 6.6 (0-10) vs. 6.1 (0-10) Past cannabis use NR NR NR NR NR NR A vs.

15. Cannabis-2022-Surv-Rep-4-Table-F5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-table-F5.xlsx
    January 01, 2022 - NR + 1.75 mg/d 3 months: 3.15 mg/d vs. 2,372 mg/d vs. … NR + 2.85 mg/d 6 months: 3.05 mg/d + 2,295.5 mg/d vs. … , severity of chronic pain, pain phenotype, pain duration, mean 24-hour pain intensity, current and past … NA 84 (21 months) Long NR None NR NR NR NR NR A vs. … B VAS (0-10 [range]): 6.6 (0-10) vs. 6.1 (0-10) Past cannabis use NR NR NR NR NR NR A vs.

16. Untitled (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/tympanostomy-tubes_research-protocol.pdf
    November 16, 2015 - recurrent” but use as a standard definition three or more well-documented and separate AOM episodes in the past … 6 months or at least four well- documented and separate AOM episodes in the past 12 months with at … AOM – recurrent acute otitis media (Three or more well-documented and separate AOM episodes in the past … 6 months or at least 4 well-documented and separate AOM episodes in the past 12 months with at least … 1 in the past 6 months)   Source: www.effectivehealthcare.ahrq.gov Published online: November

17. S143 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
    October 01, 2007 - statin initiators and those eligible for statin initiation (based on having a physician visit within 6 months … Lipoprotein measures (LDL, HDL, and TG) were assumed to be valid for up to 6 months from the date of … 6 months; at least 1 physician visit in the cohort accrual block; no diagnosis of peripheral arterial … year 0.46 0.31 �0.01 0.40 0.39 0.79 Mean no. laboratory tests in the past year 10.3 11.3 �0.01 10.5 … 10.5 0.79 Mean no. electrocardiograms in the past year 0.48 0.48 0.77 0.48 0.51 0.35 Schizophrenia

18. Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix D1 Tables (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d1.xlsx
    January 01, 2024 - treatment (ADT or RT >180 days from diagnosis); surgery, brachytherapy, chemotherapy, immunotherapy, or past … after random assignment, and then every 6 months thereafter. … hyaluronic acid, prostate volume <15 cc or >9 0cc, transurethral resection of the prostate within the past … radiotherapy or prostatectomy No other malignancy (except basal cell carcinoma or other tumors within the past … after the end of therapy, then every 2-3 months for the first year and every 6 months for the next 4

19. Cer-250-Cannabis-2024-Surv-Rep-Update-Table-E5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-table-e5.xlsx
    January 01, 2024 - NR + 1.75 mg/d 3 months: 3.15 mg/d vs. 2,372 mg/d vs. … NR + 2.85 mg/d 6 months: 3.05 mg/d + 2,295.5 mg/d vs. … , severity of chronic pain, pain phenotype, pain duration, mean 24-hour pain intensity, current and past … NA 84 (21 months) Long NR None NR NR NR NR NR A vs. … B VAS (0-10 [range]): 6.6 (0-10) vs. 6.1 (0-10) Past cannabis use NR NR NR NR NR NR A vs.

20. Nonopioid Pharmacologic Treatments for Chronic Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
    February 01, 2019 - or that which persists past the time for normal tissue healing.1 From a strictly biological perspective … 2 prescriptions for chronic pain have increased substantially in the past … ), intermediate-term treatment duration (6 to 12 months), and long-term treatment duration (≥12 months … , 6 to 12 months, and ≥12 months). … Interdisciplinary chronic pain management: past, present, and future.